Hepatitis B Lab Testing Recommendations After STD Exposure
For individuals exposed to sexually transmitted diseases (STDs), hepatitis B testing should include HBsAg (hepatitis B surface antigen) testing, with follow-up testing for anti-HBs (antibody to hepatitis B surface antigen) 1-2 months after completing vaccination if indicated. 1
Initial Assessment After STD Exposure
- Evaluate the risk of HBV infection based on the type of exposure (sexual contact) and the source's HBV status 1
- Test known sources for HBsAg to determine their infection status 1
- Assess the exposed person's immune status for HBV infection by reviewing history of hepatitis B vaccination and previous vaccine response 1
Laboratory Testing Protocol
For initial evaluation after STD exposure:
For follow-up testing after STD exposure:
Post-Exposure Prophylaxis Recommendations
- For sexual exposure to a person with acute hepatitis B, administer a single dose of HBIG (0.06 mL/kg) within 14 days of the last sexual contact 2
- Begin the hepatitis B vaccine series concurrently with HBIG administration 2
- The vaccine should be administered at a different site than the HBIG but can be given at the same time 2
- Follow-up doses of vaccine should be administered 1-2 and 4-6 months after the first dose 1
Special Considerations
- Sexual transmission accounts for the majority of HBV infections in industrialized countries, making testing particularly important after STD exposure 3
- The most common risk factors for heterosexual transmission include having multiple sex partners (more than one partner in six months) or a recent history of an STD 1
- Persons with a history of multiple sex partners or treatment for STDs appear to have an increased risk for HBV infection 1
- Studies have found a significant association between HBV infection and current or past STIs, with prevalence ratios ranging from 1.15 to 6.76 depending on the specific HBV marker and STI 4
Common Pitfalls to Avoid
- Delaying testing and prophylaxis beyond 14 days after exposure significantly reduces effectiveness 2
- Failing to complete the full vaccination series (completion rates are often low, with a median of only 30%) 5
- Not testing for anti-HBs after vaccination in immunocompromised individuals, such as those with HIV 1
- Overlooking the need for hepatitis B testing in STD evaluations despite recommendations 6
Remember that hepatitis B is unique among STDs in that a safe, effective vaccine is available, making prevention particularly important in the management of potential exposures 7.